Alexion Pharmaceuticals Inc (ALXN)

ALXN (NASDAQ:Drugs) EQUITY
$143.96
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | ALXN Avg Daily Volume: 1,731,700
Last Update: 09/25/17 - 4:00 PM EDT
Volume: 0
YTD Performance: 17.66%
Open: $0.00
Previous Close: $143.96
52 Week Range: $96.18 - $149.34
Oustanding Shares: 223,185,245
Market Cap: 31,875,316,691
6-Month Chart
TheStreet Ratings Grade for ALXN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 9 8 9
Moderate Buy 2 1 2 2
Hold 3 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.47 1.61 1.68 1.63
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 61.83
Price Earnings Comparisons:
ALXN Sector Avg. S&P 500
61.83 61.80 36.80
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
14.19% 13.16% -13.20%
GROWTH 12 Mo 3 Yr CAGR
Revenue 18.40 1.00 0.25
Net Income 176.30 0.60 0.16
EPS 162.70 0.40 0.11
Earnings for ALXN:
EBITDA 1.19B
Revenue 3.08B
Average Earnings Estimates
Qtr (09/17) Qtr (12/17) FY (12/17) FY (12/18)
Average Estimate $1.13 $1.24 $4.74 $6.43
Number of Analysts 1 1 8 1
High Estimate $1.13 $1.24 $5.17 $6.43
Low Estimate $1.13 $1.24 $4.31 $6.43
Prior Year $1.18 $1.10 $3.78 $4.74
Growth Rate (Year over Year) -4.24% 12.73% 25.40% 35.65%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Update
Sep 15, 2017 | 7:10 AM EDT
Alexion Pharmaceuticals stock coverage was initiated at RBC with an "Outperform" rating and a $161 price target.
It is good to be sitting in for Doug Kass here on the Daily Diary as we look to end the trading week on a positive note. It is also good to see the Yankees start to win close games again after losing so many of them in the weeks leading into the All-Star break. The trade they made with the White Sox to bolster their bullpen already is paying dividends.
A quantitative upgrade and chart patterns may do the trick.

Chipotle's Rally Could Resume Real Money Pro($)

I am starting to watch a couple of key price zones on the way down.
We forget that a big hedge fund or mutual fund switching out of tech winners into everything else can roil the market.
But I don't have a lot of confidence in this market beyond the intraday action.

Looking for the End of a Trend Real Money Pro($)

Alexion Pharmaceuticals presents a tradeable countertrend opportunity.
"If you work for a living, why do you kill yourself working?" -- Tuco,
If you want to stay active, you'll have to do more homework.
"There are two kinds of spurs, my friend. Those that come in by the door; those that come in by the window.." -- Tuco, "

Columnist Conversations

there is some very heavy selling today and poor price action in Facebook today.  in the first hour the st...
Stock has been roasted last five trading sessions. Time to rotate into Ford ahead of big CEO long-term plan re...
Equity futures were up slightly just before 9:30 PM Sunday night.

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.